Bayer is pressing ahead with a phase ... with prior ischaemic stroke or high-risk TIA, on top of aspirin and antiplatelet therapy. The drug numerically reduced the risk of clinical ischaemic ...

An advert for Bayer's Aspirin from the early 20th century Bayer ... Pfizer and Squibb worked on mass producing the drug during World War Two, saving thousands of soldiers’ lives.

Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...

Recent guidelines have restricted aspirin use in the primary prevention of cardiovascular disease. The American Heart ...

Aspirin use in patients with PIK3CA-mutated colorectal cancer ... “This is also an example of repurposing a safe, inexpensive, and globally available drug and it stresses the importance of genomic ...

Bayer AG said it’s seeking a US Supreme Court review of litigation over the weedkiller Roundup, its latest effort to get ...

Bayer said on Friday it was again petitioning the U.S. Supreme Court to sharply limit legal claims that its Roundup ...

Bayer said on Tuesday it was preparing market launches this year of two new drugs that could each have annual peak sales of at least $1 billion, as it seeks to strengthen its pharmaceuticals business ...

German drug maker Bayer, which is awaiting regulatory approval for its new drug, elinzanetant, expects it to hit the market soon. This latest non-hormonal treatment is anticipated to be superior ...

Researchers from Florida Atlantic University argue that doctors should consider each patient's individual risk profile rather ...

New research further solidifies findings that aspirin could be a powerful anti-cancer drug, at least in some specific cases.